1998
DOI: 10.1006/pupt.1998.0130
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Endothelin-1 at Rest and During a Short Steady-State Exercise in 21 COPD Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0
1

Year Published

2001
2001
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 5 publications
0
12
0
1
Order By: Relevance
“…In addition, in the animal model of CB, the observed vasoconstriction could be explained also by a predominant action of endothelium-derived constricting factors. Decreased NO activity and increased plasma levels of ET-1 in response to hypoxemia have been described and also could explain the pulmonary arterial vasoconstriction and pulmonary hypertension observed in COPD (56,69). Thus, vasoconstriction of pulmonary vessels associated with CAPs exposures may be the result of an effect at the level of the pulmonary vascular endothelial cells with an abnormal balance between releasing of endothelium-derived constricting factors and endothelium-derived relaxing factors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, in the animal model of CB, the observed vasoconstriction could be explained also by a predominant action of endothelium-derived constricting factors. Decreased NO activity and increased plasma levels of ET-1 in response to hypoxemia have been described and also could explain the pulmonary arterial vasoconstriction and pulmonary hypertension observed in COPD (56,69). Thus, vasoconstriction of pulmonary vessels associated with CAPs exposures may be the result of an effect at the level of the pulmonary vascular endothelial cells with an abnormal balance between releasing of endothelium-derived constricting factors and endothelium-derived relaxing factors.…”
Section: Discussionmentioning
confidence: 99%
“…In animal studies, significant mortality associated with ambient or surrogate particle inhalation or intratracheal instillation has been observed only in models where there was a preexisting endothelial injury. Human epidemiologic studies show that the increased risk of death is greater in people with COPD (3), a disease process that includes some pulmonary endothelial dysfunction (69). Further studies of CAPs on the pulmonary arterial vasculature are needed to establish the full extent and the chronicity of these demonstrated effects.…”
Section: Discussionmentioning
confidence: 99%
“…Hypoxemia is a potent inducer of ET-1 in humans and experimental animals, 14,[32][33][34][35] and arterial pO 2 Ͻ65 mm Hg is associated with significant increases in plasma ET-1 in humans. 33 Furthermore, the degree of hypoxemia correlates with induction of pulmonary prepro-ET-1 mRNA expression in the AHR KO mice, although the levels remain significantly less than WT mice. Thus, the hypoxemia exhibited by AHR KO mice at modest altitude could be responsible for the increase observed in plasma ET-1 above the already elevated basal levels.…”
Section: Discussionmentioning
confidence: 99%
“…Plasma ET-1 concentrations are also elevated in COPD patients, particularly in patients who develop nocturnal hypoxemia during the night (Trakada et al, 2001;Spiropoulos et al, 2003) and in patients with hypoxemia (Faller et al, 1998), but it is not correlated with secondary pulmonary hypertension (Bacakoglu et al, 2003). This may reflect the release of ET-1 by hypoxemia, suggesting that the release of ET-1 may contribute to pulmonary vasoconstriction and pulmonary hypertension in COPD patients.…”
Section: Formationmentioning
confidence: 99%